Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome

被引:111
作者
Suzuki, OT
Sertié, AL
Der Kaloustian, VM
Kok, F
Carpenter, M
Murray, J
Czeizel, AE
Kliemann, SE
Rosemberg, S
Monteiro, M
Olsen, BR
Passos-Bueno, MR
机构
[1] Univ Sao Paulo, Ctr Estudos Genoma Humano, Inst Biociencias, BR-05508900 Sao Paulo, Brazil
[2] Univ Sao Paulo, Dept Biol, Inst Biociencias, BR-05508900 Sao Paulo, Brazil
[3] Univ Sao Paulo, Dept Neurol, Fac Med, BR-05508900 Sao Paulo, Brazil
[4] Univ Sao Paulo, Dept Oftalmol, BR-05508900 Sao Paulo, Brazil
[5] Santa Casa Sao Paulo, Sch Med, Dept Pediat, Sao Paulo, Brazil
[6] Univ Toronto, Toronto, ON, Canada
[7] McGill Univ, Montreal, PQ, Canada
[8] Maine Med Ctr, Div Maternal Fetal Med, Portland, ME USA
[9] Univ Iowa, Iowa City, IA USA
[10] Fdm Community Control Hereditary Dis, Budapest, Hungary
[11] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
基金
巴西圣保罗研究基金会;
关键词
D O I
10.1086/344695
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Knobloch syndrome (KS) is a rare disease characterized by severe ocular alterations, including vitreoretinal degeneration associated with retinal detachment and occipital scalp defect. The responsible gene, COL18A1, has been mapped to 21q22.3, and, on the basis of the analysis of one family, we have demonstrated that a mutation affecting only one of the three COL18A1 isoforms causes this phenotype. We report here the results of the screening of both the entire coding region and the exon-intron boundaries of the COL18A1 gene (which includes 43 exons), in eight unrelated patients with KS. Besides 20 polymorphic changes, we identified 6 different pathogenic changes in both alleles of five unrelated patients with KS (three compound heterozygotes and two homozygotes). All are truncating mutations leading to deficiency of one or all collagen XVIII isoforms and endostatin. We have verified that, in exon 41, the deletion c3514-3515delCT, found in three unrelated alleles, is embedded in different haplotypes, suggesting that this mutation has occurred more than once. In addition, our results provide evidence of nonallelic genetic heterogeneity in KS. We also show that the longest human isoform (NC11-728) is expressed in several tissues (including the human eye) and that lack of either the short variant or all of the collagen XVIII isoforms causes similar phenotypes but that those patients who lack all forms present more-severe ocular alterations. Despite the small sample size, we found low endostatin plasma levels in those patients with mutations leading to deficiency of all isoforms; in addition, it seems that absence of all collagen XVIII isoforms causes predisposition to epilepsy.
引用
收藏
页码:1320 / 1329
页数:10
相关论文
共 32 条
[1]   The NC1/endostatin domain of Caenorhabditis elegans type XVIII collagen affects cell migration and axon guidance [J].
Ackley, BD ;
Crew, JR ;
Elamaa, H ;
Pihlajaniemi, T ;
Kuo, CJ ;
Kramer, JM .
JOURNAL OF CELL BIOLOGY, 2001, 152 (06) :1219-1232
[2]  
Antonarakis SE, 1998, HUM MUTAT, V11, P1
[3]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[4]   THE 2ND REPORT OF KNOBLOCH SYNDROME [J].
CZEIZEL, AE ;
GOBLYOS, P ;
KUSTOS, G ;
MESTER, E ;
PARAICZ, E .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1992, 42 (06) :777-779
[5]   Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice [J].
Eklund, L ;
Piuhola, J ;
Komulainen, J ;
Sormunen, R ;
Ongvarrasopone, C ;
Fässler, R ;
Muona, A ;
Ilves, M ;
Ruskoaho, H ;
Takala, TES ;
Pihlajaniemi, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (03) :1194-1199
[6]   Lack of collagen XVIII/endostatin results in eye abnormalities [J].
Fukai, N ;
Eklund, L ;
Marneros, AG ;
Oh, SP ;
Keene, DR ;
Tamarkin, L ;
Niemelä, M ;
Ilves, M ;
Li, E ;
Pihlajaniemi, T ;
Olsen, BR .
EMBO JOURNAL, 2002, 21 (07) :1535-1544
[7]  
Iughetti P, 2001, CANCER RES, V61, P7375
[8]  
KLIEMANN SE, IN PRESS AM J MED GE
[9]  
Knobloch WH., 1971, J PEDIATR OPHTHALMOL, V8, P181, DOI 10.3928/0191-3913-19710801-11
[10]  
Lin YF, 2001, DEVELOPMENT, V128, P1573